Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2003-07-31
2007-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
patients in this group got 100mcg of intrathecal morphine.
intra thecal morphine
100 mcg intrathecal morphine given once .
2
patients in this group got 200 mcg intrathecal morphine
intra thecal morphine
200 mcg intrathecal morphine given once
3
patients in this group given 300 mcg intrathecal morphine.
intra thecal morphine
300 mcg intrathecal morphine given once
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intra thecal morphine
100 mcg intrathecal morphine given once .
intra thecal morphine
200 mcg intrathecal morphine given once
intra thecal morphine
300 mcg intrathecal morphine given once
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* No allergy to morphine, rescue analgesia or anti-emesis treatment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College Hospital Galway
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Anaesthesia , University College Hospital Galway
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick D Hassett, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Anaesthesia, UCHG
John Laffey, MD
Role: STUDY_CHAIR
Department of Anaesthesia,UCHG
Brian Kinirons, MD
Role: STUDY_DIRECTOR
Dept of Anaesthesia , UCHG
References
Explore related publications, articles, or registry entries linked to this study.
Hassett P, Ansari B, Gnanamoorthy P, Kinirons B, Laffey JG. Determination Of The Efficacy And Side-effect Profile Of Lower Doses Of Intrathecal Morphine In Patients Undergoing Total Knee Arthroplasty. BMC Anesthesiol. 2008 Sep 24;8:5. doi: 10.1186/1471-2253-8-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0001
Identifier Type: -
Identifier Source: org_study_id